William Marth, Teva Americas President & CEO, discusses the company's leadership shuffle, what it's doing to fend off generic competition from Indian upstarts and lackluster generic drugs sales in the U.S.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT